LJPC

La Jolla Pharmaceutical Company

Delisted

LJPC was delisted on the 19th of August, 2022.

45 hedge funds and large institutions have $70.4M invested in La Jolla Pharmaceutical Company in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 23 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$102K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$386K
2 +$180K
3 +$144K
4
RWM
Ritholtz Wealth Management
New York
+$64K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$48.1K

Top Sellers

1 -$525K
2 -$346K
3 -$260K
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$123K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$109K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$41M
2
$9.94M
3
$3.52M
4
$3.02M
5
$2.56M
6
$2.04M
7
$1.82M
8
$1.02M
9
$866K
10
$593K
11
$543K
12
$422K
13
$396K
14
$386K
15
$352K
16
$341K
17
$217K
18
$188K
19
$149K
20
$144K
21
$118K
22
$112K
23
$111K
24
$108K
25
$64K